Pfizer teams up with Alloy for antibody discovery Feb. 11, 2025 9:35 AM ET Pfizer Inc. (PFE) Stock By: Val Brickates Kennedy, SA News Editor 1 Comment Play (<1min) georgeclerk ...

Pfizer is stopping development of its experimental oral GLP-1 drug for obesity, the company announced Monday, after a patient in a trial suffered a liver injury potentially caused by the drug.&nbsp… ...

Pfizer is facing another setback with its weight-loss pill, danuglipron. The pharmaceutical giant stopped development of the drug after liver issues affected one patient.

Pfizer is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist investor Starboard Value, looks to divest non-core assets, according to three ...